Vertex announces UK approval for CASGEVY™
Congratulations to Vertex for their UK approval for CASGEVY™, a CRISPR/Cas9 gene-edited therapy, for...
read DetailsModality Solutions new white paper provides a new approach to transport simulation for drug products. The goal of the drug formulation simulation study is to concurrently expose drug product to all five environmental hazards – temperature, shock, vibration, humidity, and pressure – as they occur during real-world distribution.
The white paper examines the effectiveness of simulated transport studies. It uses a holistic methodology to testing the multiple hazards in cold chain transport. In doing so, the industry best practices of the following areas are explained:
• Hot and cold exposures to a single shipment
• Non-accelerated vibration
• Exposure to multiple pressures
• Parcel-based transport simulation testing
Regulatory expectations are driving leading companies to incorporate simulated transport testing into both their development and stability programs. Learn how Modality Solutions’ Advantage Transport Simulation Laboratory™ enables the study of transport stresses on early-stage drug formulations during the development process and verification of the robustness of the commercial drug product formulation.
Click here to view the Drug Product Formulation Testing White Paper press release.
Congratulations to Vertex for their UK approval for CASGEVY™, a CRISPR/Cas9 gene-edited therapy, for...
read DetailsCongratulations to Melinta Therapeutics for their FDA Approval of REZZAYO™ for the Treatment of...
read DetailsCongratulations to Iveric Bio for their FDA approval for IZERVAY™️️, a new treatment for...
read Details